"Sneddon Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of livedo reticularis, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media. (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60)
| Descriptor ID |
D018860
|
| MeSH Number(s) |
C10.228.140.300.750 C14.907.253.774 C17.800.862.775
|
| Concept/Terms |
Sneddon Syndrome- Sneddon Syndrome
- Syndrome, Sneddon
- Sneddon-Champion Syndrome
- Sneddon Champion Syndrome
- Syndrome, Sneddon-Champion
- Livedo Reticularis And Cerebrovascular Accidents
- Livedo Reticularis, Systemic Involvement
|
Below are MeSH descriptors whose meaning is more general than "Sneddon Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Sneddon Syndrome".
This graph shows the total number of publications written about "Sneddon Syndrome" by people in this website by year, and whether "Sneddon Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sneddon Syndrome" by people in Profiles.
-
Wohlrab J, Franc?s C, Sullivan KE. Strange symptoms in Sneddon's syndrome. Clin Immunol. 2006 Apr; 119(1):13-5.